✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Jubilant Pharmova Ltd.

JUBLPHARMA

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹16,818 Cr.
P/E
36.54

Jubilant Pharmova Ltd.

  • Jubilant Pharmova
  • Caplin Point Lab
  • Natco Pharma
  • TJI Pharma - API & CRAMS
FAQs on Jubilant Pharmova Ltd. Shareprice

Jubilant Pharmova has given lower returns compared to its competitors.
Jubilant Pharmova has grown at ~4.87% over the last 8yrs while peers have grown at a median rate of 14.21%

Jubilant Pharmova is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Jubilant Pharmova is 37.28, while 3 year average PE is 44.37.
Also latest EV/EBITDA of Jubilant Pharmova is 15.27 while 3yr average is 11.91.

View FAQ's On Business
Growth Table
  • Jubilant Pharmova Ltd.
  • Caplin Point Lab
  • Natco Pharma
Balance Sheet
  • Jubilant Pharmova Ltd.
  • Caplin Point Lab
  • Natco Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Jubilant Pharmova Ltd.
  • Caplin Point Lab
  • Natco Pharma
Cash Flow
  • Jubilant Pharmova Ltd.
  • Caplin Point Lab
  • Natco Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Jubilant Pharmova Ltd.
  • Caplin Point Lab
  • Natco Pharma
Quarterly Results
  • Jubilant Pharmova Ltd.
  • Caplin Point Lab
  • Natco Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Jubilant Pharmova Ltd. Financials

Balance sheet of Jubilant Pharmova is strong.
It shouldn't have solvency or liquidity issues.

The debt of Jubilant Pharmova is decreasing.
Latest debt of Jubilant Pharmova is ₹259 Crs as of Mar-25.
This is less than Mar-24 when it was ₹1,502 Crs.

The profit is oscillating.
The profit of Jubilant Pharmova is ₹458 Crs for TTM, ₹839 Crs for Mar 2025 and ₹77.1 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Jubilant Pharmova latest dividend payout ratio is 9.41% and 3yr average dividend payout ratio is 55.94%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech